Free radicals and antioxidants in cardiovascular diseases. - Wikidata - wikimedia - TriplyDB

Free radicals and antioxidants in cardiovascular diseases.

Free radicals and antioxidants in cardiovascular diseases.

http://www.wikidata.org/entity/Q36050521

about

Gene therapy for ischemic heart disease Platelet Shape Changes and Cytoskeleton Dynamics as Novel Therapeutic Targets for Anti-Thrombotic Drugs Engineering biodegradable polyester elastomers with antioxidant properties to attenuate oxidative stress in tissues Reactive oxygen species and vascular remodelling in hypertension: still alive One-month diesel exhaust inhalation produces hypertensive gene expression pattern in healthy rats Redox compartmentalization in eukaryotic cells Antioxidant enzyme gene transfer for ischemic diseases.Effects of shear stress on endothelial cells: go with the flow.Bioactive selaginellins from Selaginella tamariscina (Beauv.) Spring.Effect of vitamin A and vitamin C supplementation on oxidative stress in HIV and HIV-TB co-infection at Lagos University Teaching Hospital (LUTH) Nigeria.Epigallocatechin-3-gallate protects HUVECs from PM2.5-induced oxidative stress injury by activating critical antioxidant pathways.Cardiopulmonary responses of Wistar Kyoto, spontaneously hypertensive, and stroke-prone spontaneously hypertensive rats to particulate matter (PM) exposure.

P2860

Q24632135-DB34F37A-5676-4EA7-B16D-4E300C7BBC19 Q28077729-FF3AF4AF-8A7E-4B94-A4AB-AF682AB446A6 Q28394340-C5EAE702-CCB4-465D-9020-13E9FAA34EE4 Q36593273-B66DA01A-2D96-4C40-A281-588CE3D7BF85 Q37064807-EA50483F-341E-4D99-9CED-C2E15BDB26E2 Q37081874-2AF4F4DE-4BE0-4E2A-9B98-94586689C902 Q37398189-CABE68F9-26C6-4A0E-A28E-6E744C24A577 Q38849620-0EE5CD93-5C03-4F3B-8F4A-17D443F85BEA Q40078362-AB9787A2-CFAF-4ACA-8F80-3AFA3FE81D0F Q45807516-1787A7B8-4111-46F0-A40A-C6C66A7555AD Q46743376-5357C2B7-A0FD-4244-A222-3D5C2698290F Q46926955-DC753151-3FA1-4FED-A15C-A36E620D338A

P2860

Free radicals and antioxidants in cardiovascular diseases.

http://www.wikidata.org/entity/Q36050521

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Free radicals and antioxidants in cardiovascular diseases.

@ast

Free radicals and antioxidants in cardiovascular diseases.

@en

type

label

Free radicals and antioxidants in cardiovascular diseases.

@ast

Free radicals and antioxidants in cardiovascular diseases.

@en

prefLabel

Free radicals and antioxidants in cardiovascular diseases.

@ast

Free radicals and antioxidants in cardiovascular diseases.

@en

P1433

Q36050521-BAF32D5D-DFCD-4858-B628-5A302BE1E3A2

P1476

Q36050521-5F4B462B-B60F-4D19-9910-AF256B4DED98

P2093

Q36050521-6BA4AD3D-EB76-4AE0-AC0B-74E5DC57F56B

P2860

Q36050521-007DEE70-68EE-4DB0-AA87-AEB9A97CC565

Q36050521-06A17A14-0132-4745-80BE-FFB23A4E1DD0

Q36050521-0EB31076-E5D7-4C6F-9535-E14973D7772B

Q36050521-130F225C-5FE8-4D37-AAA8-0B98E3652F4F

Q36050521-133D4B6A-E7D8-4913-8C6F-11F4A4B287D3

Q36050521-1353C366-7439-4C09-A54E-CA040604F129

Q36050521-1BD7862A-8ABE-4C23-B139-D67B4B5EA059

Q36050521-1E63ADF0-2282-4503-BA01-0E082FA39404

Q36050521-229A9C76-47C8-475D-B7C5-D9EDB157379A

Q36050521-24D4DFC3-E3DE-4F82-BA26-6E2956321133

P304

Q36050521-52A0378F-4B1C-4C7E-BBCE-712516A8DDE2

P31

Q36050521-88F4680F-F250-4FFF-BAD1-69A4FEADA779

P356

Q36050521-0A95EB4F-88CC-4767-9D61-E2F3A1578679

P433

Q36050521-632FEF5F-3C9D-49CD-A9CD-B66D44FD234C

P478

Q36050521-12018666-2E9F-4C02-B670-CA35004B313A

P50

Q36050521-27701F7C-4A1B-4BD8-8CD1-019BAC0917D4

P577

Q36050521-2B64D06F-17F2-4E02-8F12-005B07B283EF

P698

Q36050521-0A5A6093-9E0F-40E4-835C-0309528EB5E8

P921

Q36050521-39EB1F77-119B-42D7-B8D7-D910E9ADD200

P356

14779072.3.1.159

P1433

Expert Review of Cardiovascular Therapy

P1476

Free radicals and antioxidants in cardiovascular diseases

@en

P2093

Paolo Abrescia

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training

Vascular endothelial cells synthesize nitric oxide from L-arginine

Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide

Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.

Export by red blood cells of nitric oxide bioactivity.

Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.

P304

159-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.3.1.159

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15723584

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease